 This study found that hydrogen sulfide, H2S, a known antioxidant, could reduce renal damage caused by the chemotherapy drug sysplatin, CP. The researchers administered H2S to rats via intraperitoneal injection at doses of 200 mu G, slash kg slash day for 15 days. They observed that H2S reduced the severity of renal injury caused by CP, as evidenced by decreases in urinary protein excretion, serum urea and creatinine levels, and lipid peroxidation markers. Additionally, they found that H2S increased the expression of the proteins nephrin and desmin, which are important components of the glomerular filtration barrier. These findings suggest that H2S may be a potential therapeutic agent for preventing or reducing renal damage caused by CP. This article was authored by Asiya Kareemi, Farozen Abzalan, Liasedat Korsandi, and others. We are article.tv, links in the description below.